A new analysis led by surgeons at UCLA Health finds that psychological prehabilitation can significantly enhance recovery after surgery.
Pfizer’s $1.5B cuts; Biogen’s $1.15B buyout; AstraZeneca’s $80B ambition; RNA startup merger; and more
Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit